HRP20150944T1 - Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju - Google Patents

Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju Download PDF

Info

Publication number
HRP20150944T1
HRP20150944T1 HRP20150944TT HRP20150944T HRP20150944T1 HR P20150944 T1 HRP20150944 T1 HR P20150944T1 HR P20150944T T HRP20150944T T HR P20150944TT HR P20150944 T HRP20150944 T HR P20150944T HR P20150944 T1 HRP20150944 T1 HR P20150944T1
Authority
HR
Croatia
Prior art keywords
oxo
hydroxy
ligands
metal ions
acid
Prior art date
Application number
HRP20150944TT
Other languages
English (en)
Croatian (hr)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise Aline Bruggraber
Nuno Jorge Rodrigues Faria
Dora Isabel Amaral Pereira
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of HRP20150944T1 publication Critical patent/HRP20150944T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76Metal complexes of amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
HRP20150944TT 2007-02-06 2008-02-06 Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju HRP20150944T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
EP08709331.6A EP2125847B1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (1)

Publication Number Publication Date
HRP20150944T1 true HRP20150944T1 (hr) 2015-10-09

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150944TT HRP20150944T1 (hr) 2007-02-06 2008-02-06 Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju

Country Status (15)

Country Link
US (1) US8058462B2 (enExample)
EP (1) EP2125847B1 (enExample)
JP (1) JP5756598B2 (enExample)
KR (1) KR101514470B1 (enExample)
AU (1) AU2008212653B2 (enExample)
BR (1) BRPI0807212B1 (enExample)
CA (1) CA2676146C (enExample)
CY (1) CY1116590T1 (enExample)
EA (1) EA019635B1 (enExample)
GB (1) GB2451713B (enExample)
HR (1) HRP20150944T1 (enExample)
IL (1) IL199901A (enExample)
MX (1) MX2009008281A (enExample)
PL (1) PL2125847T3 (enExample)
WO (1) WO2008096130A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) * 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) * 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167970A1 (en) 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ferrous hydroxides
US11267836B2 (en) * 2016-03-31 2022-03-08 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
SG10202100422VA (en) 2016-08-10 2021-02-25 Res & Innovation Uk Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
ES3009466T3 (en) 2017-09-11 2025-03-27 Pharmacosmos Holding As Iron complex compounds for therapeutic use
GB202005054D0 (en) * 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
US20230338545A1 (en) * 2020-09-17 2023-10-26 Syracuse University Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
CA3226771A1 (en) 2021-08-03 2023-02-09 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017901A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (enExample)
US2575347A (en) 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
BR0212542B1 (pt) 2001-10-08 2014-04-08 Purac Biochem Bv Método para a preparação de gluconato de cálcio, mistura de sal de gluconato/sal de ácido orgânico, lactato/gluconato de cálcio, produto de alimento fortificado com cálcio, e, suco de laranja
US6770773B2 (en) * 2002-01-24 2004-08-03 William Marsh Rice University Organic acid-Fe-OOH (ferroxane) particles and ferroxane-derived ceramics and ceramic membranes
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7674780B2 (en) 2004-03-16 2010-03-09 Navinta Llc Iron sucrose complexes and method of manufacture thereof
WO2005094203A2 (en) 2004-03-16 2005-10-13 Navinta, Llc Sodium ferric gluconate complexes and method of manufacture thereof
MX2007004036A (es) 2004-10-08 2007-05-24 Unilever Nv Complejo de hierro para uso en el tratamiento y/o prevencion de trastornos nutricionales.
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
TWI468167B (zh) 2007-11-16 2015-01-11 威佛(國際)股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
GB2451713A (en) 2009-02-11
AU2008212653A1 (en) 2008-08-14
CY1116590T1 (el) 2017-03-15
AU2008212653B2 (en) 2012-05-24
GB0802214D0 (en) 2008-03-12
PL2125847T3 (pl) 2015-12-31
JP5756598B2 (ja) 2015-07-29
CA2676146C (en) 2016-08-09
KR20090121281A (ko) 2009-11-25
EA200970718A1 (ru) 2010-02-26
US20080188555A1 (en) 2008-08-07
WO2008096130A1 (en) 2008-08-14
JP2010520856A (ja) 2010-06-17
BRPI0807212B1 (pt) 2022-01-11
BRPI0807212A2 (pt) 2014-06-17
EA019635B1 (ru) 2014-05-30
IL199901A (en) 2014-11-30
US8058462B2 (en) 2011-11-15
GB2451713B (en) 2009-12-16
CA2676146A1 (en) 2008-08-14
EP2125847A1 (en) 2009-12-02
EP2125847B1 (en) 2015-06-17
IL199901A0 (en) 2010-04-15
HK1138598A1 (en) 2010-08-27
KR101514470B1 (ko) 2015-04-22
MX2009008281A (es) 2009-08-25

Similar Documents

Publication Publication Date Title
HRP20150944T1 (hr) Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
Nguyen et al. N-doping modified zeolitic imidazole Framework-67 (ZIF-67) for enhanced peroxymonosulfate activation to remove ciprofloxacin from aqueous solution
Tan et al. Activation of peroxymonosulfate by a novel EGCE@ Fe3O4 nanocomposite: Free radical reactions and implication for the degradation of sulfadiazine
JP2010520856A5 (enExample)
Xiao et al. Graphene shell-encapsulated copper-based nanoparticles (G@ Cu-NPs) effectively activate peracetic acid for elimination of sulfamethazine in water under neutral condition
Zhang et al. ZIF-67-derived carbon@ Co3S4/CoSO4/MnO polyhedron to activate peroxymonosulfate for degrading levofloxacin: Synergistic effect and mechanism
Lateef et al. Synthesis and characterization of zeolite based nano–composite: An environment friendly slow release fertilizer
Kuma et al. Photoreduction of Fe (III) by hydroxycarboxylic acids in seawater
Xu et al. Efficient removal of tetracycline using magnetic MnFe2O4/MoS2 nanocomposite activated peroxymonosulfate: Mechanistic insights and performance evaluation
So et al. Post-assembly transformations of porphyrin-containing metal–organic framework (MOF) films fabricated via automated layer-by-layer coordination
Gao et al. Mechanisms for photo assisted Fenton of synthesized pyrrhotite at neutral pH
CN102897891A (zh) 一种复合型高锰酸钾缓释剂的制备方法
Fang et al. Impact of low-molecular weight organic acids on selenite immobilization by goethite: Understanding a competitive-synergistic coupling effect and speciation transformation
JP7264895B2 (ja) 6価クロム処理剤、6価クロムを含む汚染物質の処理方法および6価クロムを含む骨粉の処理方法
Wang et al. Tea saponin co-ball milled commercial micro zero-valent iron for boosting Cr (VI) removal
Niu et al. Catalytic performance of alkaline earth metals doped-Co3O4 for azo dye degradation by peroxymonosulfate activation
JP2012075398A (ja) 鉄イオン供給材
Cojocaru et al. Intensification of organic pollutant degradation under visible light irradiation using ZnO nanostructured photocatalysts doped with praseodymium
Gylienė et al. Copper (II)–EDTA sorption onto chitosan and its regeneration applying electrolysis
CN115873601A (zh) 重金属钝化剂、土壤修复材料及镉砷复合污染物修复方法
Yu et al. New insights into enhanced catalytic degradation of sulfamethoxazole using Fe-Zn@ biochar composite-activated periodate system: The combination of radical and non-radical pathways
Luo et al. A Co-based nitrogen-doped lignin carbon catalyst with high stability and wide operating window for rapid degradation of antibiotics
Ma et al. Photo-assisted oxygen-rich vacancy copper oxide catalyst to activate peroxymonosulfate (PMS) for efficient degradation of fulvic acid
Wang et al. Different water matrixes leading to noticeable differences of tetracycline removal by ZnO
Zheng et al. A cost-effective pH-sensitive release system for water source pH detection